Digital Sponsored From PDURS to D2C, Frontiers Health speaks to cutting edge h... Premiere healthcare innovation event Frontiers Health is just under a month away.
Market Access Part 1: Accelerating the medical, legal and regulatory (MLR)... Medical, legal and regulatory review (MLR review) of promotional as well as non-promotional materials is one of the core responsibilities of medical and commercial teams within any life sci
R&D Reducing drug shortages: The power of AI in pharma supply ch... Drug shortages have long been a challenge in the pharmaceutical industry, causing significant disruptions to patient care and public health.
Market Access Balancing innovation and safety: The impact of Medtech regul... The Medtech sector is currently at a crossroads, facing a potential choice between rapid technological advancement and strict regulatory oversight.
Digital Adopting AI platforms: A structured framework for thoughtful... The adoption of AI platforms, particularly in sectors such as drug discovery and healthcare, is a complex and critical process.
Digital Tech & Trials: What’s all this about AI, then? Welcome to Tech & Trials – a guided tour to the world of AI and clinical trials.
News Repligen builds in cell therapy with $1.5bn BioLife takeover Repligen has reached a deal to buy cell therapy specialist BioLife Solutions for $1.5bn, tapping into a market growing at breakneck speed.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
